MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
PR Newswire —
NEW YORK, Feb. 7, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. A class action...